Nucochem Pediatric Expectorant Interactions
There are 651 drugs known to interact with Nucochem Pediatric Expectorant (codeine / guaifenesin / pseudoephedrine), along with 22 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 132 are major, 514 are moderate, and 5 are minor.
- View all 651 medications that may interact with Nucochem Pediatric Expectorant
- View Nucochem Pediatric Expectorant alcohol/food interactions (2)
- View Nucochem Pediatric Expectorant disease interactions (22)
Most frequently checked interactions
View interaction reports for Nucochem Pediatric Expectorant (codeine / guaifenesin / pseudoephedrine) and the medicines listed below.
- acetaminophen
- amlodipine
- Benadryl (diphenhydramine)
- caffeine
- cyclobenzaprine
- duloxetine
- Emgality (galcanezumab)
- hydroxychloroquine
- hydroxyzine
- Nurtec ODT (rimegepant)
- omeprazole
- ondansetron
- Percocet 5 / 325 (acetaminophen / oxycodone)
- Pradaxa (dabigatran)
- riboflavin
- sertraline
- sumatriptan
- trazodone
- Ubrelvy (ubrogepant)
Nucochem Pediatric Expectorant alcohol/food interactions
There are 2 alcohol/food interactions with Nucochem Pediatric Expectorant (codeine / guaifenesin / pseudoephedrine).
Nucochem Pediatric Expectorant disease interactions
There are 22 disease interactions with Nucochem Pediatric Expectorant (codeine / guaifenesin / pseudoephedrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Report options
More about Nucochem Pediatric Expectorant (codeine / guaifenesin / pseudoephedrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.